View in EDS PDF Full Text

Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities.

Saved in:
Bibliographic Details
Title: Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities.
Authors: Waterhouse DN; Experimental Therapeutics, BC Cancer Agency, Vancouver, BC, Canada., Sutherland BW, Santos ND, Masin D, Osooly M, Strutt D, Ostlund C, Anantha M, Harasym N, Manisali I, Wehbe M, Bally MB, Webb MS
Source: Investigational new drugs [Invest New Drugs] 2014 Dec; Vol. 32 (6), pp. 1071-82. Date of Electronic Publication: 2014 Jul 27.
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25064374
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Waterhouse+DN%22">Waterhouse DN</searchLink>; Experimental Therapeutics, BC Cancer Agency, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Sutherland+BW%22">Sutherland BW</searchLink><br /><searchLink fieldCode="AU" term="%22Santos+ND%22">Santos ND</searchLink><br /><searchLink fieldCode="AU" term="%22Masin+D%22">Masin D</searchLink><br /><searchLink fieldCode="AU" term="%22Osooly+M%22">Osooly M</searchLink><br /><searchLink fieldCode="AU" term="%22Strutt+D%22">Strutt D</searchLink><br /><searchLink fieldCode="AU" term="%22Ostlund+C%22">Ostlund C</searchLink><br /><searchLink fieldCode="AU" term="%22Anantha+M%22">Anantha M</searchLink><br /><searchLink fieldCode="AU" term="%22Harasym+N%22">Harasym N</searchLink><br /><searchLink fieldCode="AU" term="%22Manisali+I%22">Manisali I</searchLink><br /><searchLink fieldCode="AU" term="%22Wehbe+M%22">Wehbe M</searchLink><br /><searchLink fieldCode="AU" term="%22Bally+MB%22">Bally MB</searchLink><br /><searchLink fieldCode="AU" term="%22Webb+MS%22">Webb MS</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309330%22">Investigational new drugs</searchLink> [Invest New Drugs] 2014 Dec; Vol. 32 (6), pp. 1071-82. <i>Date of Electronic Publication: </i>2014 Jul 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309330 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-0646 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676997%22">01676997 </searchLink><i>NLM ISO Abbreviation: </i>Invest New Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25064374
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10637-014-0138-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1071
    Titles:
      – TitleFull: Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Waterhouse DN
      – PersonEntity:
          Name:
            NameFull: Sutherland BW
      – PersonEntity:
          Name:
            NameFull: Santos ND
      – PersonEntity:
          Name:
            NameFull: Masin D
      – PersonEntity:
          Name:
            NameFull: Osooly M
      – PersonEntity:
          Name:
            NameFull: Strutt D
      – PersonEntity:
          Name:
            NameFull: Ostlund C
      – PersonEntity:
          Name:
            NameFull: Anantha M
      – PersonEntity:
          Name:
            NameFull: Harasym N
      – PersonEntity:
          Name:
            NameFull: Manisali I
      – PersonEntity:
          Name:
            NameFull: Wehbe M
      – PersonEntity:
          Name:
            NameFull: Bally MB
      – PersonEntity:
          Name:
            NameFull: Webb MS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2014 Dec
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1573-0646
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Investigational new drugs
              Type: main
ResultId 1